Search Results 1631-1640 of 20442 for hepatitis

1. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

   - Have active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. - Has an active autoimmune disease that has required systemic treatment in the ...

2. Mayo Clinic Transplant Center - Doctors

   Transplant Hepatologist. Rochester, MN. Areas of focus: Liver transplant, Cholestasis of pregnancy, Hepatocellular carcinoma, Alcoholic hepatitis, Gallbladder ...

3. Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, and Acute Myeloid Leukemia - Mayo Clinic

   Known infection with human immunodeficiency virus (HIV), or an active infection with hepatitis B or hepatitis C. Concomitant disease or condition that could ...

4. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   Patients with known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection. Part 2 only: Patients with a ...

5. A Study of CDX-1127 (Varlilumab) in Patients with Select Solid Tumor Types or Hematologic Cancers - Mayo Clinic

   Active infection requiring systemic therapy, known HIV infection, or positive test for hepatitis B surface antigen or hepatitis C. Is being treated for anti ...

6. First-in-Human Study of FLX925 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Patients known to be positive for hepatitis B or to have active hepatitis C infection; Any evidence of ongoing graft-versus-host disease (GVHD) in subjects ...

7. A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms - Mayo Clinic

   - Known significant liver disease (e.g., acute hepatitis, chronic active hepatitis, cirrhosis, or signs of coagulopathy) or known hepatic insufficiency ...

8. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

   * Subjects with chronic hepatitis B virus (HBV) infection with active disease who meet the criteria for anti-HBV therapy and are not on a suppressive ...

9. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Patients with known chronic active hepatitis B (defined as a positive hepatitis B surface antigen and/or hepatitis B viral load in the last 12 months) are ...

10. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

    * Known history of hepatitis B, hepatitis C requiring antiviral treatment * Human immunodeficiency virus (HIV)-infected patients on effective anti ...